Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.74 |
| ▸ | MAPT | P10636 | 5/20 | 0.74 |
| ▸ | MEN1 | O00255 | 5/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.74 |
| ▸ | HTT | P42858 | 2/20 | 0.74 |
| ▸ | RECQL | P46063 | 2/20 | 0.74 |
| ▸ | BLM | P54132 | 2/20 | 0.74 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.74 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.74 |
| ▸ | GNG2 | P59768 | 1/20 | 0.60 |
| ▸ | GNB1 | P62873 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31326016 | 0.89 | FTO (0.76) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL17201722 | 0.87 | GNG2 (0.76) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL29756279 | 0.87 | FTO (0.73) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL8417826 | 0.87 | FTO (0.73) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL20907331 | 0.87 | FTO (0.73) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL8607854 | 0.87 | FTO (0.73) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL3652107 | 0.87 | FTO (0.73) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL5359408 | 0.87 | FTO (0.73) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL17025371 | 0.86 | FTO (0.68) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL499201 | 0.86 | FTO (0.68) | FTOMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0889324-B1 | Process for the determination of potassium ions | NOVARTIS AG (CH) | 2006-09-13 | — | — | EP | claimed |
| US-5099020-A | Immunoassay with fluorescent compounds | ABBOTT LABORATORIES (US) | 1992-03-24 | — | — | US | claimed |
| WO-2022038359-A1 | CROSS-LINKING METHOD AND APPLICATIONS IN BIOCONJUGATION | UNIVERSITY OF DURHAM (GB) | 2022-02-24 | — | — | WO | disclosed |
| US-20080152640-A1 | Means and Methods For Treating a Disease Which is Associated With an Excess Transport of Hyaluronan Across a Lipid Bilayer | UNIVERSITATSKLINIKUM MUNSTER (DE) | 2008-06-26 | — | — | US | disclosed |
| US-20070221884-A1 | Liminescent Silicon Oxide Flakes | CIBA SPECIALTY CHEMICALS CORP. | 2007-09-27 | — | — | US | disclosed |
| EP-1468107-A4 | METHODS AND REAGENTS FOR IMPROVED CELL-BASED ASSAYS | BECKMAN COULTER INC (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1769049-A2 | LUMINESCENT SILICON OXIDE FLAKES | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-04-04 | — | — | EP | disclosed |
| EP-0889324-B1 | Process for the determination of potassium ions | NOVARTIS AG (CH) | 2006-09-13 | — | — | EP | disclosed |
| WO-2006008239-A2 | LUMINESCENT SILICON OXIDE FLAKES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-01-26 | — | — | WO | disclosed |
| EP-1468107-A2 | METHODS AND REAGENTS FOR IMPROVED CELL-BASED ASSAYS | Beckman-Coulter, Inc. (US) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003034025-A2 | METHODS AND REAGENTS FOR IMPROVED CELL-BASED ASSAYS | BECKMAN-COULTER, INC. (US) | 2003-04-24 | — | — | WO | disclosed |
| EP-1036763-B1 | Process for the preparation of coloured and fluorescent polysilicic acid particles | MICROMOD PARTIKELTECHNOLOGIE G (DE) | 2001-12-05 | — | — | EP | disclosed |
| US-6245574-B1 | ACTIVE LAYER CONTAINS A POLYMER IN WHICH IS DISPERSED AT LEAST ONE MODIFIED VALINOMYCIN, IN WHICH A RADICAL OF A FLUORESCENCE DYE WHICH EMITS IN LONG WAVES, PREFERABLY AN ACRIDINE OR FLUORESCEIN | NOVARTIS AG (CH) | 2001-06-12 | — | — | US | disclosed |
| EP-1036763-A1 | Process for the preparation of coloured and fluorescent polysilicic acid particles | micromod Partikeltechnologie GmbH (DE) | 2000-09-20 | — | — | EP | disclosed |
| EP-0889324-A1 | Sensors for the determination of potassium ions | Novartis AG (CH) | 1999-01-07 | — | — | EP | disclosed |
| US-5776720-A | COMPOUND OR SALT FOR ASSAYING ACTIVITY OF AN ENZYME INSIDE A METABOLICALLY ACTIVE WHOLE CELL | COULTER CORPORATION (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0832279-A1 | AN ASSAY REAGENT AND A METHOD OF MAKING AND USING THE ASSAY REAGENT | Coulter International Corp. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996036729-A1 | AN ASSAY REAGENT AND A METHOD OF MAKING AND USING THE ASSAY REAGENT | COULTER INTERNATIONAL CORP. (US) | 1996-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080152640-A1 | Means and Methods For Treating a Disease Which is Associated With an Excess Transport of Hyaluronan Across a Lipid Bilayer | ABCB1, ABCB11, SLC47A2 | FTO 3724/4885MAPT 2282/4885MEN1 3590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.